May 29th 2023
The senior scientist at Tune Therapeutics discussed preclinical research presented at the ASGCT 2023 meeting.
Carol Miao, PhD, on Exploring New Delivery Methods for Gene Replacement Therapy and Gene EditingMay 26th 2023
The principal investigator at Seattle Children’s Research Institute discussed the preclinical research on delivery methods for genomic medicines that her lab presented at ASGCT’s 2023 meeting.
Bringing HLA-A*02-directed CAR T to Solid Tumor Care With the EVEREST-1 Trial
Diane M. Simeone, MD, discussed the phase 1/2 EVEREST-1 trial, which seeks to assess the novel CAR T-cell therapy A2B530 in patients with solid tumors—hopefully progressing one-and-done engineered therapies in this population.